🏛️ Verified NIH Record • Updated 2025-09-17
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction (NCT06294574)
🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: University of Alabama at Birmingham
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the study is to test how successful the retrieval rate of the new HydroMARK Plus Breast Biopsy Site Marker in comparison to HydroMARK.
Who can join: Review the eligibility criteria below.
Location: The Kirklin Clinic — Birmingham, Alabama
Age range: 18 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- The Kirklin Clinic — Birmingham, Alabama
📞 Contact the Study Coordinator
Phone: (205) 996-1082
Email: qmooney@uabmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Neoplasm
- Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer — Phoenix, Arizona
- Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer — Houston, Texas
- [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer — Philadelphia, Pennsylvania
- A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients — Aitkin, Minnesota
- MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC — Toronto, Ontario
- Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. — México,
Explore by condition: All Breast Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.